Cargando…
In depth characterization of midbrain organoids derived from wild type iPSC lines
The ability to model human neurological tissues in vitro has been a major hurdle to effective drug development for neurological disorders. iPSC-derived brain organoids have emerged as a compelling solution to this problem as they have the potential to relevantly model the protein expression pattern...
Autores principales: | Pavlinov, Ivan, Tambe, Mitali, Abbott, Joshua, Nguyen, Ha Nam, Xu, Miao, Pradhan, Manisha, Farkhondeh, Atena, Zheng, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588847/ https://www.ncbi.nlm.nih.gov/pubmed/37862312 http://dx.doi.org/10.1371/journal.pone.0292926 |
Ejemplares similares
-
Generation and characterization of NGLY1 patient-derived midbrain organoids
por: Abbott, Joshua, et al.
Publicado: (2023) -
Human iPSC-derived midbrain organoids functionally integrate into striatum circuits and restore motor function in a mouse model of Parkinson's disease
por: Zheng, Xin, et al.
Publicado: (2023) -
Merits and challenges of iPSC-derived organoids for clinical applications
por: Xu, Ziran, et al.
Publicado: (2023) -
iPSC-Derived Organoids as Therapeutic Models in Regenerative Medicine and Oncology
por: Turhan, Ali G., et al.
Publicado: (2021) -
Application of an iPSC‐Derived Organoid Model for Localized Scleroderma Therapy
por: Ma, Jie, et al.
Publicado: (2022)